Asia-Pacific Absorbable and Non-Absorbable Sutures Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Asia-Pacific Absorbable and Non-Absorbable Sutures Market Size

• The Asia-Pacific Absorbable and Non-Absorbable Sutures market size was valued at USD 752.80 Million in 2025 and is expected to reach USD 1183.64 Million by 2033, at a CAGR of 5.82% during the forecast period
• The market growth is largely fueled by the rising number of surgical procedures globally, increasing prevalence of chronic diseases, and growing demand for advanced wound closure solutions across hospitals and ambulatory surgical centers. Technological advancements in suture materials, including antimicrobial coatings, improved tensile strength, and enhanced biocompatibility, are contributing to greater adoption in both general and specialized surgical applications
• Furthermore, the growing preference for minimally invasive surgeries, faster wound healing, and reduced post-operative complications is establishing absorbable and non-absorbable sutures as essential components of modern surgical practice. Expanding healthcare infrastructure in emerging economies and continuous product innovations by medical device manufacturers are accelerating the uptake of absorbable and non-absorbable suture solutions, thereby significantly boosting overall market growth

Asia-Pacific Absorbable and Non-Absorbable Sutures Market Analysis

• Absorbable and non-absorbable sutures, used for wound closure and tissue approximation during surgical procedures, are essential components of modern surgical care across hospitals, ambulatory surgical centers, and specialty clinics due to their reliability, tensile strength, and compatibility with a wide range of surgical applications including cardiovascular, orthopedic, gynecological, and general surgeries
• The escalating demand for absorbable and non-absorbable sutures is primarily fueled by the rising number of surgical procedures globally, increasing prevalence of chronic diseases, expanding geriatric population, and growing preference for minimally invasive surgeries that require advanced wound closure materials. Continuous innovations such as antimicrobial-coated sutures and enhanced biocompatible materials are further supporting market expansion
• China dominated the absorbable and non-absorbable sutures market with the largest revenue share of approximately 22.8% in 2025, driven by a high surgical volume, rapidly expanding healthcare infrastructure, strong domestic manufacturing capabilities, and increasing government investments in hospital modernization. The country continues to witness substantial growth in demand for advanced surgical consumables across public and private healthcare facilities
• India is expected to be the fastest-growing country in the absorbable and non-absorbable sutures market during the forecast period, projected to register a CAGR of approximately 10.2%, supported by improving healthcare access, rising medical tourism, increasing number of multispecialty hospitals, and growing awareness regarding advanced surgical wound management solutions
• The Sutures segment dominated the largest market revenue share of 64.2% in 2025, driven by their extensive use across a wide range of surgical specialties including general surgery, orthopedics, cardiovascular, and gynecology

Report Scope and Absorbable and Non-Absorbable Sutures Market Segmentation       

Asia-Pacific Absorbable and Non-Absorbable Sutures Market Trends

Shift Toward Advanced and Antimicrobial Suture Materials

• A significant and accelerating trend in the Asia-Pacific absorbable and non-absorbable sutures market is the growing adoption of advanced suture materials designed to enhance wound healing and reduce post-surgical complications
• Healthcare providers across countries such as China, India, Japan, and South Korea are increasingly utilizing synthetic absorbable sutures and antimicrobial-coated variants to minimize surgical site infections (SSIs) and improve patient recovery outcomes.
  • For instance, companies such as Ethicon offer antibacterial-coated absorbable sutures that are widely used in hospitals to reduce the risk of infection during surgical procedures
• These innovations are gaining traction across tertiary care hospitals and specialty surgical centers in the region
• In addition, there is a growing preference for minimally invasive and cosmetic surgical procedures, which require finer, high-performance suturing materials with improved tensile strength and predictable absorption profiles
• The expansion of private healthcare facilities and rising medical tourism in Asia-Pacific are further encouraging the adoption of premium suturing solutions. This technological evolution in suture design and material composition is reshaping surgical practices across the region

Asia-Pacific Absorbable and Non-Absorbable Sutures Market Dynamics

Driver

Rising Surgical Procedures and Expanding Healthcare Infrastructure

• The increasing number of surgical procedures across Asia-Pacific is a primary driver of the absorbable and non-absorbable sutures market
• Rapid population growth, rising incidence of chronic diseases, increasing trauma cases, and expanding access to healthcare services are contributing to higher surgical volumes in both public and private hospitals
  • For instance, the growing burden of cardiovascular diseases and orthopedic disorders in countries like India and China has led to a significant rise in bypass surgeries, joint replacements, and trauma-related operations, all of which require reliable suturing materials for wound closure and internal tissue repair
• Furthermore, government initiatives aimed at strengthening healthcare infrastructure, along with investments in new hospitals and ambulatory surgical centers, are supporting greater adoption of surgical consumables
• The expansion of health insurance coverage and improved affordability of surgical treatments are also driving demand for both absorbable and non-absorbable sutures across urban and semi-urban areas in the region

Restraint/Challenge

Price Sensitivity and Availability of Alternative Wound Closure Methods

• Despite strong growth prospects, the Asia-Pacific absorbable and non-absorbable sutures market faces challenges related to price sensitivity and competition from alternative wound closure technologies
• Many healthcare facilities in developing economies operate under strict budget constraints, leading to preference for low-cost conventional sutures over premium or specialized variants
  • For instance, in cost-sensitive markets, hospitals may opt for locally manufactured sutures rather than higher-priced imported products, impacting the market share of multinational brands
• In addition, the increasing adoption of alternative wound closure products such as surgical staplers, tissue adhesives, and hemostatic agents is intensifying competition within the surgical consumables segment
• Variability in regulatory standards across countries and the presence of counterfeit or substandard products in certain markets further pose risks to quality assurance and patient safety
• Addressing these challenges through competitive pricing strategies, local manufacturing expansion, improved regulatory compliance, and clinician education will be essential for sustaining long-term growth in the Asia-Pacific absorbable and non-absorbable sutures market

Asia-Pacific Absorbable and Non-Absorbable Sutures Market Scope

The market is segmented on the basis of product type, surgery type, and end users.

• By Product Type

On the basis of product type, the Pacific Absorbable and Non-Absorbable Sutures market is segmented into Automated Suturing Devices and Sutures. The Sutures segment dominated the largest market revenue share of 64.2% in 2025, driven by their extensive use across a wide range of surgical specialties including general surgery, orthopedics, cardiovascular, and gynecology. Conventional absorbable and non-absorbable sutures remain the standard choice for wound closure due to their cost-effectiveness, availability, and surgeon familiarity. Increasing surgical volumes across Pacific countries significantly support demand. The rising prevalence of chronic diseases requiring surgical intervention further strengthens segment growth. Additionally, continuous product innovations such as antibacterial-coated and synthetic absorbable sutures enhance patient outcomes. Expanding hospital infrastructure and improving access to surgical care in developing Pacific nations also contribute to dominance. Strong distribution networks and affordability further reinforce the widespread adoption of sutures.

The Automated Suturing Devices segment is anticipated to witness the fastest growth rate of 9.8% CAGR from 2026 to 2033, fueled by increasing demand for minimally invasive and time-efficient surgical procedures. These devices improve precision, reduce operative time, and minimize surgeon fatigue. Growing adoption of laparoscopic and robotic-assisted surgeries is significantly accelerating product uptake. Technological advancements enhancing safety and ease of use further drive demand. Rising investments in advanced surgical equipment across tertiary hospitals strengthen future growth prospects. Additionally, increasing preference for standardized wound closure techniques in complex surgeries contributes to expanding adoption across the region.

• By Surgery Type

On the basis of surgery type, the Pacific Absorbable and Non-Absorbable Sutures market is segmented into Cardiovascular, Orthopedic, Gynecology, Ophthalmology, General Surgery, and Others. The General Surgery segment accounted for the largest market revenue share of 31.6% in 2025, primarily due to the high volume of abdominal, gastrointestinal, and soft tissue procedures performed annually. Sutures are extensively utilized in both minor and major surgical interventions to ensure secure wound closure. Increasing incidence of appendectomies, hernia repairs, and tumor resections significantly supports segment growth. Expanding healthcare access and rising hospitalization rates further drive demand. Surgeons continue to rely on a wide range of absorbable and non-absorbable sutures for optimal healing outcomes. Improvements in surgical techniques and infrastructure across Pacific nations also reinforce segment dominance.

The Cardiovascular Surgery segment is projected to witness the fastest CAGR of 8.7% from 2026 to 2033, driven by the growing burden of cardiovascular diseases in the Pacific region. Rising numbers of bypass surgeries, valve replacements, and vascular repair procedures significantly increase suture demand. Advanced non-absorbable sutures are widely used in delicate cardiac and vascular operations. Technological advancements in high-strength and biocompatible materials further support growth. Increasing healthcare expenditure and expansion of cardiac specialty centers contribute to the segment’s rapid expansion.

• By End Users

On the basis of end users, the Pacific Absorbable and Non-Absorbable Sutures market is segmented into Hospitals, Ambulatory Centers, Clinics, Community Healthcare, and Others. The Hospitals segment dominated the largest market revenue share of 52.4% in 2025, attributed to high patient inflow and the performance of complex and emergency surgical procedures. Large hospitals are equipped with advanced surgical infrastructure and skilled professionals, ensuring consistent product utilization. Rising government investments in hospital expansion across Pacific countries further strengthen this segment. Increasing trauma cases and chronic disease-related surgeries significantly contribute to demand. Additionally, favorable reimbursement policies and procurement systems in public and private hospitals support sustained growth.

The Ambulatory Centers segment is expected to witness the fastest CAGR of 9.3% from 2026 to 2033, driven by the increasing shift toward outpatient and minimally invasive procedures. These centers offer cost-effective surgical services with shorter recovery times. Growing patient preference for same-day discharge and reduced hospital stays accelerates demand for sutures in ambulatory settings. Expansion of private surgical centers across urban Pacific regions further boosts growth. Technological advancements and improved accessibility to advanced wound closure products continue to strengthen future prospects for this segment.

Asia-Pacific Absorbable and Non-Absorbable Sutures Market Regional Analysis

• The Asia-Pacific absorbable and non-absorbable sutures market is poised to grow at the fastest CAGR of approximately 9.6% during the forecast period of 2026 to 2033, driven by expanding healthcare infrastructure, rising surgical volumes, and increasing healthcare expenditure across emerging economies
• Rapid urbanization and growing disposable incomes in countries such as China, India, and Japan are improving access to advanced surgical treatments. Governments across the region are heavily investing in hospital modernization and public healthcare expansion, further supporting demand for surgical consumables
• The increasing prevalence of chronic diseases, trauma cases, and elective surgical procedures is significantly boosting the utilization of both absorbable and non-absorbable sutures. Additionally, the expansion of private hospital networks and medical tourism hubs across Asia-Pacific is accelerating product adoption. Growing awareness regarding infection control and advanced wound management solutions is further strengthening market growth

China Absorbable and Non-Absorbable Sutures Market Insight

The China absorbable and non-absorbable sutures market dominated the Asia-Pacific region with the largest revenue share of approximately 22.8% in 2025, driven by high surgical procedure volumes and rapidly expanding healthcare infrastructure. The country’s large population base and increasing incidence of chronic conditions significantly contribute to consistent surgical demand. Strong domestic manufacturing capabilities enable cost-effective production and wide distribution of sutures across public and private healthcare facilities. Government investments in hospital modernization and healthcare reforms are enhancing procedural capacity nationwide. Increasing adoption of advanced synthetic and antibacterial-coated sutures is further supporting market expansion. Additionally, rising medical insurance coverage and growing awareness of quality surgical care are accelerating product utilization across tertiary and secondary hospitals.

India Absorbable and Non-Absorbable Sutures Market Insight

The India absorbable and non-absorbable sutures market is expected to be the fastest-growing country in the region, projected to register a CAGR of approximately 10.2% from 2026 to 2033. Growth is supported by improving healthcare access, increasing government healthcare spending, and expansion of multispecialty hospitals across urban and semi-urban areas. Rising medical tourism and growing demand for cost-effective surgical treatments significantly contribute to procedural growth. Increasing awareness regarding advanced wound management solutions and infection prevention is driving adoption of high-quality sutures. Expansion of private healthcare providers and insurance penetration further strengthen market prospects. Additionally, supportive government initiatives aimed at strengthening public healthcare infrastructure continue to accelerate the demand for surgical consumables across the country.

Asia-Pacific Absorbable and Non-Absorbable Sutures Market Share

The Absorbable and Non-Absorbable Sutures industry is primarily led by well-established companies, including:

• Johnson & Johnson (U.S.)
• Medtronic plc (Ireland)
• B. Braun S.E. (Germany)
• Smith & Nephew plc (U.K.)
• Stryker Corporation (U.S.)
• Zimmer Biomet Holdings, Inc. (U.S.)
• Teleflex Incorporated (U.S.)
• CONMED Corporation (U.S.)
• Peters Surgical (France)
• DemeTECH Corporation (U.S.)
• Healthium Medtech Limited (India)
• Lotus Surgicals Pvt Ltd (India)
• Internacional Farmacéutica S.A. de C.V. (Mexico)
• Boston Scientific Corporation (U.S.)
• Apollo Endosurgery, Inc. (U.S.)
• Sutures India Pvt. Ltd. (India)
• CP Medical (U.S.)
• Riverpoint Medical (U.S.)

Latest Developments in Asia-Pacific Absorbable and Non-Absorbable Sutures Market

• In July 2024, B. Braun announced the launch of a new absorbable suture line in India through a strategic distribution partnership with Sutures India, expanding access to advanced suture solutions in the fast-growing Asia-Pacific region
• In September 2024, Johnson & Johnson Services announced the launch of its new ETHICON Plus Suture portfolio with an enhanced antimicrobial coating designed to further reduce the risk of surgical site infections in high-risk procedures. This expanded portfolio aims to improve post-operative outcomes and support enhanced wound healing across general and specialty surgeries
• In November 2024, Medtronic Plc received U.S. FDA 510(k) clearance for its V-Loc 2.0 barbed absorbable suture, featuring a new design for improved tissue anchoring in robotic-assisted and minimally invasive surgeries, broadening clinical applications for barbed suture technology
• In November 2024, Medtronic secured a multi-year contract to supply absorbable and non-absorbable sutures to a major national healthcare network in Europe, reinforcing its position as a key global supplier of suture products
• In January 2025, B. Braun SE completed the acquisition of a European med-tech startup specializing in sensor-integrated smart suture technology for real-time wound healing monitoring. The acquisition, valued at an estimated USD 75 million, strengthens B. Braun’s portfolio with next-generation digital suture systems
• In March 2025, according to Wise Guy Reports, Ethicon announced a strategic collaboration with Teleflex to co-develop an advanced barbed absorbable suture system engineered for faster and more secure wound closure, expanding the technological roadmap of absorbable sutures globally
• In April 2025, Boston Scientific Corp. formed a strategic alliance with a leading polymer science firm to co-develop a novel bioresorbable polymer with superior elasticity aimed at next-generation cardiovascular and soft-tissue sutures, signaling collaborative innovation in suture materials technology

SKU-2834